ID

4867

Beschreibung

ODM derived from http://clinicaltrials.gov/show/NCT01435616

Link

http://clinicaltrials.gov/show/NCT01435616

Stichworte

Versionen (3)
  1. 07.02.12 07.02.12 -
  2. 13.04.14 13.04.14 - Julian Varghese
  3. 17.09.21 17.09.21 -
Hochgeladen am

13. April 2014

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility NCT01435616 Diabetes Mellitus, Type 2

Deutsch Englisch

Eligibility

1 Formulare  
  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alter 18 Jahre und älter
Beschreibung

Age

Datentyp

boolean

Have type 2 diabetes mellitus, not treated with insulin, for at least one year prior to the study
Beschreibung

Diabetes mellitus, Type 2

Datentyp

boolean

Have been receiving at least 2 oral antihyperglycemic medication for at least 3 months before entering the study
Beschreibung

antihyperglycemic medication

Datentyp

boolean

Have hemoglobin A1c value between 7.0% and 11.0%, inclusive, at screening
Beschreibung

HbA1c 7-11%

Datentyp

boolean

Are capable of, and willing to inject insulin with a vial and syringe and perform self blood glucose monitoring
Beschreibung

Insulin therapy and blood glucose monitoring

Datentyp

boolean

Woman of Childbearing potential only: are not breastfeeding, have a negative pregnancy test at the time of screening and randomization and intend to not become pregnant during the trial. Have practiced a reliable method of birth control for at least 6 weeks prior to screening and agree to use a reliable method of birth control during the study and until 2 weeks following the last dose of study drug
Beschreibung

no pregnancy, no breastfeeding

Datentyp

boolean

Exclusion Criteria
Beschreibung

Exclusion Criteria

Have used insulin therapy (outside of pregnancy) anytime in the past 2 years, except for short-term treatment of acute conditions, and up to a maximum of 4 continuous weeks
Beschreibung

Insulin therapy

Datentyp

boolean

Use of rosiglitazone, pramlintide, glucagon-like peptide 1 (GLP-1) receptor agonist (for example, exenatide, exenatide once weekly, or liraglutide) concurrently or within 3 months prior to screening
Beschreibung

Other medications

Datentyp

boolean

Are currently taking, or have taken within the 3 months preceding screening, medications to promote weight loss
Beschreibung

medication for weight loss

Datentyp

boolean

Have had any episodes of severe hypoglycemia within 6 months prior to screening
Beschreibung

Hypoglycemia

Datentyp

boolean

Have had 1 or more episodes of ketoacidosis or hyperosmolar state/coma in the 6 months prior to the study
Beschreibung

Ketoacidosis

Datentyp

boolean

Have cardiac disease with functional status that is New York Heart Association Class III or IV (per New York Heart Association [NYHA] Cardiac Disease Classification)
Beschreibung

Cardiac disease

Datentyp

boolean

Have a history of renal transplantation, or are currently receiving renal dialysis or have serum creatinine greater or equal than 2 mg/dL
Beschreibung

Renal transplantation

Datentyp

boolean

Have obvious clinical signs or symptoms of liver disease (excluding non- alcoholic fatty liver disease [NAFLD]), acute or chronic hepatitis, non-alcoholic steatohepatitis (NASH), or elevated liver enzyme measurements at screening
Beschreibung

Liver disease

Datentyp

boolean

Have had a blood transfusion or severe blood loss within 3 months prior to screening or have known hemoglobinopathy, hemolytic anemia or sickle cell anemia, or any other traits of hemoglobin abnormalities known to interfere with the measurement of hemoglobin A1c
Beschreibung

Blood transfusion

Datentyp

boolean

Have active or untreated malignancy, have been in remission from clinically significant malignancy for less than 5 years
Beschreibung

Malignancy

Datentyp

boolean

Have fasting or nonfasting triglycerides greater than 400 mg/dL (greater than 4.5 mmol/L) at screening
Beschreibung

Triglycerides greater than 400 mg/dL

Datentyp

boolean

Are using lipid lowering medication at a dose that has not been stable for 90 days prior to screening
Beschreibung

Lipid lowering medication

Datentyp

boolean

Are using niacin preparations as a lipid lowering medication and bile acid sequestrants within 90 days prior to screening
Beschreibung

Niacin and bile acid sequestrants

Datentyp

boolean

Medical Concepts
Beschreibung

Medical Concepts

Alter
Beschreibung

Age

Datentyp

string

Alias
UMLS CUI
C0001779
SNOMED CT 2010_0731
102518004
Diagnose
Beschreibung

Diagnosis

Datentyp

string

Alias
UMLS CUI
C0011900
SNOMED CT 2010_0731
439401001
LOINC Version 232
MTHU008876
Diabetes mellitus Typ II
Beschreibung

Diabetes mellitus type 2

Datentyp

string

Alias
UMLS CUI
C0011860
SNOMED CT 2010_0731
44054006
MedDRA 13.1
10012613
ICD-10-CM Version 2010
E08-E13
Anti-hyperglycemics
Beschreibung

Hypoglycemic agents

Datentyp

string

Alias
UMLS CUI
C0020616
SNOMED CT 2010_0731
373299009
LOINC Version 232
MTHU016642
HbA1c
Beschreibung

Glycosylated hemoglobin A

Datentyp

string

Alias
UMLS CUI
C0019018
SNOMED CT 2010_0731
33601001
LOINC Version 232
MTHU018890
Self-monitoring of blood glucose
Beschreibung

Blood Glucose Self-Monitoring

Datentyp

string

Alias
UMLS CUI
C0005803
SNOMED CT 2010_0731
308113006
Serum pregnancy test (B-HCG)
Beschreibung

Serum pregnancy test

Datentyp

string

Alias
UMLS CUI
C0430060
SNOMED CT 2010_0731
166434005
Kontrazeption
Beschreibung

Contraception

Datentyp

string

Alias
UMLS CUI
C0700589
SNOMED CT 2010_0731
146680009
MedDRA 13.1
10010808
Breast feeding, Nursing
Beschreibung

Lactation

Datentyp

string

Alias
UMLS CUI
C0006147
MedDRA 13.1
10006247
Insulin
Beschreibung

Therapeutic insulin

Datentyp

string

Alias
UMLS CUI
CL318047
Medikation
Beschreibung

Pharmaceutical Preparations

Datentyp

string

Alias
UMLS CUI
C0013227
SNOMED CT 2010_0731
C0061355
MedDRA 13.1
43004008
rosiglitazone
Beschreibung

rosiglitazone

Datentyp

string

Alias
UMLS CUI
C0289313
Pramlintide
Beschreibung

Pramlintide

Datentyp

string

Alias
UMLS CUI
C0537551
GLP-1 Receptor Agonist
Beschreibung

Glucagon-like Peptide 1 Receptor Agonist

Datentyp

string

Alias
UMLS CUI
C2917359
Weight-Loss Drugs
Beschreibung

Weight-Loss Drugs

Datentyp

string

Alias
UMLS CUI
C0376606
Hypoglykämie
Beschreibung

Hypoglycemia

Datentyp

string

Alias
UMLS CUI
C0220982
SNOMED CT 2010_0731
56051008
MedDRA 13.1
10023379
Ketoazidose
Beschreibung

Ketoacidosis

Datentyp

string

Alias
UMLS CUI
C0018799
SNOMED CT 2010_0731
56265001
MedDRA 13.1
10061024
Hyperosmolar coma associated with diabetes mellitus
Beschreibung

Hyperosmolar coma associated with diabetes mellitus

Datentyp

string

Alias
UMLS CUI
C1720143
SNOMED CT 2010_0731
422126006
Herzkrankheit
Beschreibung

Cardiac disease

Datentyp

string

Alias
UMLS CUI
C1275491
SNOMED CT 2010_0731
420816009
NYHA
Beschreibung

NYHA

Datentyp

string

Alias
UMLS CUI
C0022671
SNOMED CT 2010_0731
70536003
MedDRA 13.1
10038533
ICD-9-CM Version 2011
55.6
Nierentransplantation
Beschreibung

Kidney Transplantation

Datentyp

string

Alias
UMLS CUI
C0917873
SNOMED CT 2010_0731
265764009
MedDRA 13.1
10049051
Renal dialysis
Beschreibung

Renal dialysis

Datentyp

string

Alias
UMLS CUI
C0023895
SNOMED CT 2010_0731
235856003
MedDRA 13.1
10024670
ICD-10-CM Version 2010
K76.9
ICD-9-CM Version 2011
573.9
Liver diseases
Beschreibung

Liver disorder

Datentyp

string

Alias
UMLS CUI
C0023895
SNOMED CT 2010_0731
116859006
MedDRA 13.1
10005835
LOINC Version 232
MTHU020992
Bluttransfusion
Beschreibung

Blood transfusion

Datentyp

string

Alias
UMLS CUI
C0005841
SNOMED CT 2010_0731
363346000
MedDRA 13.1
10028997
LOINC Version 232
MTHU010328
ICD-10-CM Version 2010
C80
ICD-9-CM Version 2011
199
Malignant Neoplasms
Beschreibung

Malignant Neoplasms

Datentyp

string

Alias
UMLS CUI
C0006826
SNOMED CT 2010_0731
85600001
LOINC Version 232
MTHU003166
Triglyceride
Beschreibung

Triglycerides

Datentyp

string

Alias
UMLS CUI
C1277252
SNOMED CT 2010_0731
135822005
Lipid lowering drug
Beschreibung

Antilipemic agent

Datentyp

string

Alias
UMLS CUI
C0003367
SNOMED CT 2010_0731
57952007
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility

1 Formulare
  1. StudyEvent: Eligibility
    1. Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Age
Item
Alter 18 Jahre und älter
boolean
Diabetes mellitus, Type 2
Item
Have type 2 diabetes mellitus, not treated with insulin, for at least one year prior to the study
boolean
antihyperglycemic medication
Item
Have been receiving at least 2 oral antihyperglycemic medication for at least 3 months before entering the study
boolean
HbA1c 7-11%
Item
Have hemoglobin A1c value between 7.0% and 11.0%, inclusive, at screening
boolean
Insulin therapy and blood glucose monitoring
Item
Are capable of, and willing to inject insulin with a vial and syringe and perform self blood glucose monitoring
boolean
no pregnancy, no breastfeeding
Item
Woman of Childbearing potential only: are not breastfeeding, have a negative pregnancy test at the time of screening and randomization and intend to not become pregnant during the trial. Have practiced a reliable method of birth control for at least 6 weeks prior to screening and agree to use a reliable method of birth control during the study and until 2 weeks following the last dose of study drug
boolean
Insulin therapy
Item
Have used insulin therapy (outside of pregnancy) anytime in the past 2 years, except for short-term treatment of acute conditions, and up to a maximum of 4 continuous weeks
boolean
Other medications
Item
Use of rosiglitazone, pramlintide, glucagon-like peptide 1 (GLP-1) receptor agonist (for example, exenatide, exenatide once weekly, or liraglutide) concurrently or within 3 months prior to screening
boolean
medication for weight loss
Item
Are currently taking, or have taken within the 3 months preceding screening, medications to promote weight loss
boolean
Hypoglycemia
Item
Have had any episodes of severe hypoglycemia within 6 months prior to screening
boolean
Ketoacidosis
Item
Have had 1 or more episodes of ketoacidosis or hyperosmolar state/coma in the 6 months prior to the study
boolean
Cardiac disease
Item
Have cardiac disease with functional status that is New York Heart Association Class III or IV (per New York Heart Association [NYHA] Cardiac Disease Classification)
boolean
Renal transplantation
Item
Have a history of renal transplantation, or are currently receiving renal dialysis or have serum creatinine greater or equal than 2 mg/dL
boolean
Liver disease
Item
Have obvious clinical signs or symptoms of liver disease (excluding non- alcoholic fatty liver disease [NAFLD]), acute or chronic hepatitis, non-alcoholic steatohepatitis (NASH), or elevated liver enzyme measurements at screening
boolean
Blood transfusion
Item
Have had a blood transfusion or severe blood loss within 3 months prior to screening or have known hemoglobinopathy, hemolytic anemia or sickle cell anemia, or any other traits of hemoglobin abnormalities known to interfere with the measurement of hemoglobin A1c
boolean
Malignancy
Item
Have active or untreated malignancy, have been in remission from clinically significant malignancy for less than 5 years
boolean
Triglycerides greater than 400 mg/dL
Item
Have fasting or nonfasting triglycerides greater than 400 mg/dL (greater than 4.5 mmol/L) at screening
boolean
Lipid lowering medication
Item
Are using lipid lowering medication at a dose that has not been stable for 90 days prior to screening
boolean
Niacin and bile acid sequestrants
Item
Are using niacin preparations as a lipid lowering medication and bile acid sequestrants within 90 days prior to screening
boolean
Age
Item
Alter
string
C0001779 (UMLS CUI)
102518004 (SNOMED CT 2010_0731)
Diagnosis
Item
Diagnose
string
C0011900 (UMLS CUI)
439401001 (SNOMED CT 2010_0731)
MTHU008876 (LOINC Version 232)
Diabetes mellitus type 2
Item
Diabetes mellitus Typ II
string
C0011860 (UMLS CUI)
44054006 (SNOMED CT 2010_0731)
10012613 (MedDRA 13.1)
E08-E13 (ICD-10-CM Version 2010)
Hypoglycemic agents
Item
Anti-hyperglycemics
string
C0020616 (UMLS CUI)
373299009 (SNOMED CT 2010_0731)
MTHU016642 (LOINC Version 232)
Glycosylated hemoglobin A
Item
HbA1c
string
C0019018 (UMLS CUI)
33601001 (SNOMED CT 2010_0731)
MTHU018890 (LOINC Version 232)
Blood Glucose Self-Monitoring
Item
Self-monitoring of blood glucose
string
C0005803 (UMLS CUI)
308113006 (SNOMED CT 2010_0731)
Serum pregnancy test
Item
Serum pregnancy test (B-HCG)
string
C0430060 (UMLS CUI)
166434005 (SNOMED CT 2010_0731)
Contraception
Item
Kontrazeption
string
C0700589 (UMLS CUI)
146680009 (SNOMED CT 2010_0731)
10010808 (MedDRA 13.1)
Lactation
Item
Breast feeding, Nursing
string
C0006147 (UMLS CUI)
10006247 (MedDRA 13.1)
Therapeutic insulin
Item
Insulin
string
CL318047 (UMLS CUI)
Pharmaceutical Preparations
Item
Medikation
string
C0013227 (UMLS CUI)
C0061355 (SNOMED CT 2010_0731)
43004008 (MedDRA 13.1)
rosiglitazone
Item
rosiglitazone
string
C0289313 (UMLS CUI)
Pramlintide
Item
Pramlintide
string
C0537551 (UMLS CUI)
Glucagon-like Peptide 1 Receptor Agonist
Item
GLP-1 Receptor Agonist
string
C2917359 (UMLS CUI)
Weight-Loss Drugs
Item
Weight-Loss Drugs
string
C0376606 (UMLS CUI)
Hypoglycemia
Item
Hypoglykämie
string
C0220982 (UMLS CUI)
56051008 (SNOMED CT 2010_0731)
10023379 (MedDRA 13.1)
Ketoacidosis
Item
Ketoazidose
string
C0018799 (UMLS CUI)
56265001 (SNOMED CT 2010_0731)
10061024 (MedDRA 13.1)
Hyperosmolar coma associated with diabetes mellitus
Item
Hyperosmolar coma associated with diabetes mellitus
string
C1720143 (UMLS CUI)
422126006 (SNOMED CT 2010_0731)
Cardiac disease
Item
Herzkrankheit
string
C1275491 (UMLS CUI)
420816009 (SNOMED CT 2010_0731)
NYHA
Item
NYHA
string
C0022671 (UMLS CUI)
70536003 (SNOMED CT 2010_0731)
10038533 (MedDRA 13.1)
55.6 (ICD-9-CM Version 2011)
Kidney Transplantation
Item
Nierentransplantation
string
C0917873 (UMLS CUI)
265764009 (SNOMED CT 2010_0731)
10049051 (MedDRA 13.1)
Renal dialysis
Item
Renal dialysis
string
C0023895 (UMLS CUI)
235856003 (SNOMED CT 2010_0731)
10024670 (MedDRA 13.1)
K76.9 (ICD-10-CM Version 2010)
573.9 (ICD-9-CM Version 2011)
Liver disorder
Item
Liver diseases
string
C0023895 (UMLS CUI)
116859006 (SNOMED CT 2010_0731)
10005835 (MedDRA 13.1)
MTHU020992 (LOINC Version 232)
Blood transfusion
Item
Bluttransfusion
string
C0005841 (UMLS CUI)
363346000 (SNOMED CT 2010_0731)
10028997 (MedDRA 13.1)
MTHU010328 (LOINC Version 232)
C80 (ICD-10-CM Version 2010)
199 (ICD-9-CM Version 2011)
Malignant Neoplasms
Item
Malignant Neoplasms
string
C0006826 (UMLS CUI)
85600001 (SNOMED CT 2010_0731)
MTHU003166 (LOINC Version 232)
Triglycerides
Item
Triglyceride
string
C1277252 (UMLS CUI)
135822005 (SNOMED CT 2010_0731)
Antilipemic agent
Item
Lipid lowering drug
string
C0003367 (UMLS CUI)
57952007 (SNOMED CT 2010_0731)
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video